Sustained complete remission in a patient with platinum-resistant ovarian yolk sac tumor.
Gynecol Oncol
; 82(3): 578-80, 2001 Sep.
Article
in En
| MEDLINE
| ID: mdl-11520160
ABSTRACT
BACKGROUND:
Yolk sac tumors of the ovary are generally very responsive to chemotherapy; however, they are difficult to manage in the setting of platinum resistance where treatment options are limited and outcomes are poorer. CASE We present a 39-year-old woman who had a platinum-resistant yolk sac ovarian tumor. She achieved complete remission on an innovative regimen of docetaxel, gemcitabine, and thalidomide.CONCLUSION:
The combination of docetaxel, gemcitabine, and thalidomide might be an active regimen for platinum-resistant ovarian nondysgerminomas and further investigation of this combination is warranted.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Endodermal Sinus Tumor
/
Taxoids
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Gynecol Oncol
Year:
2001
Document type:
Article
Affiliation country:
Estados Unidos